{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:58:06Z","timestamp":1761155886687,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Fight for Life Charity"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.clon.2014.11.006","type":"journal-article","created":{"date-parts":[[2014,12,22]],"date-time":"2014-12-22T18:28:38Z","timestamp":1419272918000},"page":"160-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Defining the Target in Cancer of the Oesophagus: Direct Radiotherapy Planning with Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography"],"prefix":"10.1016","volume":"27","author":[{"given":"F.","family":"le Grange","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Wickers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Warry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Warrilow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bomanji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.S.","family":"Tobias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2014.11.006_bib1","unstructured":"Cancer Registration Statistics, England, 2011. Available at: http:\/\/www.ons.gov.uk\/ons\/rel\/vsob1\/cancer-statistics-registrations\u2013england\u2013series-mb1-\/no\u201342\u20132011\/stb-cancer-statistics-registrations-2011.html. [accessed 11.03.14]."},{"key":"10.1016\/j.clon.2014.11.006_bib2","unstructured":"Cancer incidence and mortality in the UK, 2008\u20132010. Available at: http:\/\/www.ons.gov.uk\/ons\/rel\/cancer-unit\/cancer-incidence-and-mortality\/2008-2010\/stb-cancer-incidence-and-mortality-in-the-united-kindom\u20132008-2010.html [accessed 11.03.14]."},{"issue":"17","key":"10.1016\/j.clon.2014.11.006_bib3","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","article-title":"Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01)","volume":"281","author":"Cooper","year":"1999","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.clon.2014.11.006_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002092.pub3","article-title":"Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus","author":"Wong","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.clon.2014.11.006_bib5","series-title":"Practical radiotherapy planning","first-page":"13","article-title":"Oesophagus","author":"Dobbs","year":"1999"},{"key":"10.1016\/j.clon.2014.11.006_bib6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2214\/ajr.181.3.1810785","article-title":"Diagnosis, staging, and follow-up of esophageal cancer","volume":"181","author":"Iyer","year":"2003","journal-title":"J\u00a0Roentgenol"},{"issue":"2","key":"10.1016\/j.clon.2014.11.006_bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijrobp.2006.09.015","article-title":"Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma","volume":"67","author":"Gao","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.clon.2014.11.006_bib8","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ijrobp.2008.04.062","article-title":"Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy","volume":"73","author":"Button","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.clon.2014.11.006_bib9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1470-2045(13)70136-0","article-title":"Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2\/3 randomised trial","volume":"14","author":"Crosby","year":"2013","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clon.2014.11.006_bib10","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1088\/0031-9155\/54\/1\/R01","article-title":"Biological imaging in radiation therapy: role of positron emission tomography","volume":"54","author":"Nestle","year":"2009","journal-title":"Phys Med Biol"},{"issue":"1","key":"10.1016\/j.clon.2014.11.006_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.radonc.2008.11.008","article-title":"Use of PET and PET\/CT for radiation therapy planning: IAEA expert report 2006\u20132007","volume":"91","author":"MacManus","year":"2009","journal-title":"Radiother Oncol"},{"issue":"1 (Suppl.)","key":"10.1016\/j.clon.2014.11.006_bib12","first-page":"68S","article-title":"PET-based treatment planning in radiotherapy: a new standard?","volume":"48","author":"Gr\u00e9goire","year":"2007","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.clon.2014.11.006_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.radonc.2010.07.015","article-title":"PET in radiotherapy planning: particularly exquisite test or pending and experimental tool?","volume":"96","author":"Gregoire","year":"2010","journal-title":"Radiother Oncol"},{"issue":"8","key":"10.1016\/j.clon.2014.11.006_bib14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00066-005-1422-7","article-title":"Positron emission tomography for radiation treatment planning","volume":"181","author":"Grosu","year":"2005","journal-title":"Strahlenther Onkol"},{"issue":"1 (Suppl.)","key":"10.1016\/j.clon.2014.11.006_bib15","first-page":"78S","article-title":"Improvements in cancer staging with PET\/CT: literature-based evidence as of September 2006","volume":"48","author":"Czernin","year":"2007","journal-title":"J\u00a0Nucl Med"},{"issue":"1 (Suppl.)","key":"10.1016\/j.clon.2014.11.006_bib16","first-page":"45S","article-title":"Can PET\/CT replace separate diagnostic CT for cancer imaging? Optimizing CT protocols for imaging cancers of the chest and abdomen","volume":"48","author":"Kuehl","year":"2007","journal-title":"J\u00a0Nucl Med"},{"issue":"1","key":"10.1016\/j.clon.2014.11.006_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijrobp.2008.04.015","article-title":"Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus","volume":"73","author":"Zhong","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.clon.2014.11.006_bib18","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.ijrobp.2009.07.1681","article-title":"Comparison of 18F-fluorothymidine and 18F-fluorodeoxyglucose PET\/CT in delineating gross tumour volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus","volume":"76","author":"Han","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"18","key":"10.1016\/j.clon.2014.11.006_bib19","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1200\/JCO.2000.18.18.3202","article-title":"Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma","volume":"18","author":"Flamen","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.clon.2014.11.006_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.clon.2011.09.006","article-title":"Evidence-based guideline recommendations on the use of positron emission tomography imaging in oesophageal cancer","volume":"24","author":"Wong","year":"2012","journal-title":"Clin Oncol"},{"issue":"5","key":"10.1016\/j.clon.2014.11.006_bib21","first-page":"808","article-title":"Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET","volume":"41","author":"Choi","year":"2000","journal-title":"J\u00a0Nucl Med"},{"issue":"8","key":"10.1016\/j.clon.2014.11.006_bib22","first-page":"1255","article-title":"Additional value of PET\/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer","volume":"47","author":"Yuan","year":"2006","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.clon.2014.11.006_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.radonc.2010.04.024","article-title":"A\u00a0systematic review on the role of FDG-PET\/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer","volume":"97","author":"Muijs","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2014.11.006_bib24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.radonc.2010.07.019","article-title":"Clinical evidence on PET-CT for radiation therapy planning in gastro-intestinal tumors","volume":"96","author":"Lambrecht","year":"2010","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.clon.2014.11.006_bib25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.radonc.2004.10.001","article-title":"Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?","volume":"73","author":"Vrieze","year":"2004","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.clon.2014.11.006_bib26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1440-1673.2006.01578.x","article-title":"Influence of F-fluorodeoxyglucose-positron emission tomography on computed tomography-based radiation treatment planning for oesophageal cancer","volume":"50","author":"Everitt","year":"2006","journal-title":"Australas Radiol"},{"issue":"1","key":"10.1016\/j.clon.2014.11.006_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijrobp.2006.09.033","article-title":"Impact of hybrid fluorodeoxyglucose positron-emission tomography\/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer","volume":"67","author":"Gondi","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.clon.2014.11.006_bib28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.radonc.2006.02.014","article-title":"A\u00a0prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer","volume":"78","author":"Leong","year":"2006","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.clon.2014.11.006_bib29","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ijrobp.2005.02.039","article-title":"Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma","volume":"63","author":"Moureau-Zabotto","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.clon.2014.11.006_bib30","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.ijrobp.2008.07.061","article-title":"Impact of manual and automated interpretation of fused PET\/CT data on esophageal target definitions in radiation planning","volume":"72","author":"Hong","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.clon.2014.11.006_bib31","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ijrobp.2004.07.717","article-title":"The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma","volume":"61","author":"Konski","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2014.11.006_bib32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.radonc.2009.08.030","article-title":"Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer","volume":"93","author":"Muijs","year":"2009","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clon.2014.11.006_bib33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ijrobp.2008.01.019","article-title":"Where do we draw the line? Contouring tumors on positron emission tomography\/computed tomography","volume":"71","author":"Macmanus","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2014.11.006_bib34","first-page":"547","article-title":"\u00c9tude comparative de la distribution florale dans une portion des Alpes et des Jura","volume":"37","author":"Jaccard","year":"1901","journal-title":"Bull Soc Vaud Sci Nat"},{"issue":"7","key":"10.1016\/j.clon.2014.11.006_bib35","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.clon.2010.05.006","article-title":"Geometrical analysis of radiotherapy target volume delineation: a systematic review of reported comparison methods","volume":"22","author":"Hanna","year":"2010","journal-title":"Clin Oncol"},{"issue":"4","key":"10.1016\/j.clon.2014.11.006_bib36","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.ijrobp.2012.01.094","article-title":"Toward semi-automated assessment of target volume delineation in radiotherapy trials: the SCOPE 1 pretrial test case","volume":"84","author":"Gwynne","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2014.11.006_bib37","unstructured":"NHS England. B02: PET-CT. 2014. Available at: http:\/\/www.england.nhs.uk\/ourwork\/commissioning\/spec-services\/npc-crg\/group-b\/b02\/. [accessed 30.09.14]."},{"issue":"3","key":"10.1016\/j.clon.2014.11.006_bib38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.radonc.2012.10.015","article-title":"Oesophageal tumour progression between the diagnostic 18F-FDG-PET and the 18F-FDG-PET for radiotherapy treatment planning","volume":"106","author":"Muijs","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2014.11.006_bib39","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.radonc.2010.07.009","article-title":"PET\/CT (and CT) instrumentation, image reconstruction and data transfer for radiotherapy planning","volume":"96","author":"Sattler","year":"2010","journal-title":"Radiother Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655514004221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655514004221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:40:47Z","timestamp":1760542847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655514004221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0936655514004221"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2014.11.006","relation":{},"ISSN":["0936-6555"],"issn-type":[{"type":"print","value":"0936-6555"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining the Target in Cancer of the Oesophagus: Direct Radiotherapy Planning with Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2014.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}